Header Logo

Connection

Joan Walker to Bortezomib

Back to Details
This is a "connection" page, showing publications Joan Walker has written about Bortezomib.
Joan Walker
Connection Strength
0.036
Bortezomib
  1. A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 05; 145(2):236-242.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.